Երկիր: Միացյալ Թագավորություն
Լեզու: անգլերեն
Աղբյուրը: MHRA (Medicines & Healthcare Products Regulatory Agency)
Senna fruit
Forum Health Products Ltd
A06AB06
Senna fruit
7.5mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 01060200; GTIN: 5000158062504
%7561/'4+0(1 Õ*Ì-âir Ç°ää«Ì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i>Ãi Ìi Ì >Ì >Þ Ü ÀiÃÕÌ «>«iÀ > VÕÀ V«ià >ÃÃV>Ìi` ÜÌ Ì Ã L à Õ` Li ÀiviÀÀi` Ì vÀ VÌiÌ] >ÞÕÌ >` VÕÀ Ãi«>À>Ì Þ° 567&+1 75' 10.; X 5Or#TVEJGEM TGUWNVU %WVVGT )WKFGU 6GEJPKECN 0QP2TKPVKPI +VGOU %WVVGT KHCRRNKECDNG )WKFGU KHCRRNKECDNG /WNVK2CEMCIKPI5QNWVKQPU $QWTPG7- 5MV.DN&ZOO 64 5GNH #FJGUKXG 2CRGT9JKVG 7- % 5QWPFCTK5CTCXCPCP 0# rÓÆ"r£Æ,räÆ -- äÎÉäÉÓ£ £{\xx\£Ç 4$#TVYQTMCPF 2TKPV5RGEKƂECVKQP & #TVYQTM 6[RG $9 %QOOGTEKCN OO (.: 2TQEGUU ;GNNQY (.: 2#0610' % (.: 2#0610' % (.: 2#0610' % (.: 2#0610' % (.: 840*KIJ)NQUU78 1RV $TKIJVGPGT (.: #FJGUKXGA&GCFGPGT (.: 4GNGCUG 8CTPKUJ (.: $TCKNNG %QNQWTU .CDGN A2GGN 4GCF 4$*%QPVCEV #NGZCPFGT 6KVOWU %QPPCWIJV *QWUG %QPPCWIJV 4QCF -KPIUYQQF $WUKPGUU 2CTM*WNN *7 #2 'PINCPF 6 1 , " , 1-/Ƃ --"1/- Ƃ,/7", Ƃ/ , 7/"1/ *,", * ,--" ,"/, /° S e n o k o t t a b l e t s T B R 2 8 8 5 - D 8 3 7 2 1 5 8 – E n g l i s h 3209058 7.5 mg Tablets Senna Pods Senna Pods g 500 TABLETS POM Each tablet cont Կարդացեք ամբողջական փաստաթուղթը
OBJECT 1 SENOKOT 7.5MG TABLETS Summary of Product Characteristics Updated 22-Oct-2020 | Forum Health Products Limited • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Senokot 7.5mg Tablets 2. Qualitative and quantitative composition Each tablet contains powdered Alexandrian Senna fruit (pods) (_Cassia senna _L. (_C. acutifolia _Delile)) and Tinnevelly Senna fruit (pods) (_Cassia angustifolia _Vahl) equivalent to 7.5mg hydroxyanthracene glycosides, calculated as sennoside B. Each tablet also contains 15.82 mg lactose monohydrate For full list of excipients, see section 6.1 3. Pharmaceutical form Tablets 4. Clinical particulars 4.1 Therapeutic indications For the short-term relief of occasional constipation 4.2 Posology and method of administration For oral administration. The correct individual dose is the smallest required to produce a comfortable soft-formed motion. 500 Tablets Adults, the elderly and children over 12 years: Swallow one to two tablets at night A higher d Կարդացեք ամբողջական փաստաթուղթը